<bill session="109" type="s" number="334" updated="2020-02-10T17:00:21Z">
  <state datetime="2005-02-09">REFERRED</state>
  <status>
    <introduced datetime="2005-02-09"/>
  </status>
  <introduced datetime="2005-02-09"/>
  <titles>
    <title type="short" as="introduced">Pharmaceutical Market Access and Drug Safety Act of 2005</title>
    <title type="display">Pharmaceutical Market Access and Drug Safety Act of 2005</title>
    <title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="D000432"/>
  <cosponsors>
    <cosponsor bioguide_id="B000468" joined="2005-02-09"/>
    <cosponsor bioguide_id="B000711" joined="2005-02-09"/>
    <cosponsor bioguide_id="B001210" joined="2006-09-25"/>
    <cosponsor bioguide_id="C001040" joined="2005-02-09"/>
    <cosponsor bioguide_id="C001041" joined="2005-02-09"/>
    <cosponsor bioguide_id="C001035" joined="2005-02-09"/>
    <cosponsor bioguide_id="C000705" joined="2005-02-09"/>
    <cosponsor bioguide_id="D000596" joined="2005-02-09"/>
    <cosponsor bioguide_id="D000563" joined="2005-02-09"/>
    <cosponsor bioguide_id="F000061" joined="2005-02-09"/>
    <cosponsor bioguide_id="F000062" joined="2005-02-09"/>
    <cosponsor bioguide_id="G000386" joined="2005-02-09"/>
    <cosponsor bioguide_id="I000025" joined="2005-02-09"/>
    <cosponsor bioguide_id="J000072" joined="2005-02-09"/>
    <cosponsor bioguide_id="J000177" joined="2005-02-09"/>
    <cosponsor bioguide_id="K000105" joined="2005-02-09"/>
    <cosponsor bioguide_id="K000148" joined="2006-03-06"/>
    <cosponsor bioguide_id="K000305" joined="2005-02-09"/>
    <cosponsor bioguide_id="L000174" joined="2005-02-09"/>
    <cosponsor bioguide_id="L000261" joined="2005-02-09"/>
    <cosponsor bioguide_id="L000035" joined="2005-03-02"/>
    <cosponsor bioguide_id="L000447" joined="2005-02-09"/>
    <cosponsor bioguide_id="M000303" joined="2005-02-09"/>
    <cosponsor bioguide_id="N000032" joined="2005-02-09"/>
    <cosponsor bioguide_id="O000167" joined="2005-02-09"/>
    <cosponsor bioguide_id="P000590" joined="2005-02-09"/>
    <cosponsor bioguide_id="S001163" joined="2005-02-09"/>
    <cosponsor bioguide_id="S000064" joined="2005-02-09"/>
    <cosponsor bioguide_id="S000148" joined="2005-02-09"/>
    <cosponsor bioguide_id="S000663" joined="2005-02-09"/>
    <cosponsor bioguide_id="S000709" joined="2005-02-16"/>
    <cosponsor bioguide_id="S000770" joined="2005-02-09"/>
    <cosponsor bioguide_id="W000779" joined="2006-09-21"/>
  </cosponsors>
  <actions>
    <action datetime="2005-01-26">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S540-541"/>
    </action>
    <action datetime="2005-02-09">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2005-02-09">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S1206"/>
    </action>
    <action datetime="2005-02-09" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
    <action datetime="2005-02-10">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S1253-1254"/>
    </action>
    <action datetime="2005-04-19">
      <text>Committee on Health, Education, Labor, and Pensions. Hearings held. Hearings printed: S.Hrg. 109-143.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Hearings, Referral"/>
  </committees>
  <relatedbills>
    <bill session="109" type="h" number="700" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Accreditation (Medical care)"/>
    <term name="Administrative fees"/>
    <term name="Administrative procedure"/>
    <term name="Administrative remedies"/>
    <term name="Australia"/>
    <term name="Business records"/>
    <term name="Canada"/>
    <term name="Civil Rights and Liberties, Minority Issues"/>
    <term name="Civil actions and liability"/>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Consumer education"/>
    <term name="Contracts"/>
    <term name="Crime and Law Enforcement"/>
    <term name="Customs administration"/>
    <term name="Damages"/>
    <term name="Defective products"/>
    <term name="Department of Health and Human Services"/>
    <term name="Directories"/>
    <term name="Drug advertising"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="East Asia"/>
    <term name="Economics and Public Finance"/>
    <term name="Education"/>
    <term name="Electronic commerce"/>
    <term name="Electronic data interchange"/>
    <term name="Electronic government information"/>
    <term name="Europe"/>
    <term name="European Union"/>
    <term name="Evidence (Law)"/>
    <term name="Export controls"/>
    <term name="Exports"/>
    <term name="Federal Trade Commission"/>
    <term name="Federal-state relations"/>
    <term name="Finance and Financial Sector"/>
    <term name="Fines (Penalties)"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Foreign Trade and International Finance"/>
    <term name="Forfeiture"/>
    <term name="Fraud"/>
    <term name="Government Operations and Politics"/>
    <term name="Government paperwork"/>
    <term name="Government publicity"/>
    <term name="Governmental investigations"/>
    <term name="Higher education"/>
    <term name="Identification devices"/>
    <term name="Import restrictions"/>
    <term name="Imports"/>
    <term name="Independent regulatory commissions"/>
    <term name="Injunctions"/>
    <term name="Intellectual property"/>
    <term name="Interactive media"/>
    <term name="Internet"/>
    <term name="Japan"/>
    <term name="Labeling"/>
    <term name="Law"/>
    <term name="Liability (Law)"/>
    <term name="Licenses"/>
    <term name="Medical associations"/>
    <term name="Medical education"/>
    <term name="Medical records"/>
    <term name="Medical tests"/>
    <term name="New Zealand"/>
    <term name="Oceania"/>
    <term name="Packaging"/>
    <term name="Parties to actions"/>
    <term name="Patent infringement"/>
    <term name="Patents"/>
    <term name="Pharmaceutical research"/>
    <term name="Pharmacies"/>
    <term name="Pharmacists"/>
    <term name="Physical examinations"/>
    <term name="Prescription pricing"/>
    <term name="Price discrimination"/>
    <term name="Product counterfeiting"/>
    <term name="Restrictive trade practices"/>
    <term name="Right of privacy"/>
    <term name="Science, Technology, Communications"/>
    <term name="Surety and fidelity"/>
    <term name="Switzerland"/>
    <term name="Telephone"/>
    <term name="User charges"/>
    <term name="Web sites"/>
    <term name="Wholesale trade"/>
  </subjects>
  <amendments/>
  <summary date="2005-04-15T21:13:08Z" status="Introduced in Senate">Pharmaceutical Market Access and Drug Safety Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States.

Prohibits the importation of a qualifying drug unless such drug is imported by: (1) a registered importer; or (2) an individual for personal use.

Establishes registration conditions for importers and exporters. Requires the Secretary to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions.

Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences.

 Prohibits manufacturers from: (1) discriminating against registered exporters or importers; (2) causing there to be a difference in a prescription drug distributed in the United States and one distributed in a permitted country; (3) engaging in actions to restrict, prohibit, or delay the importation of a qualifying drug; or (4) engaging in any action that the Federal Trade Commission (FTC) determines discriminates against a person that engages or attempts to engage in the importation of a qualifying drug.

States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement.

Requires the Secretary to educate consumers regarding prescription drug importation.

Sets forth provisions governing the sale of prescription drugs through an Internet site. Includes the dispensing or selling of a prescription drug in violation of this Act as a prohibited act under FFDCA.</summary>
</bill>
